  Extracellular vesicles (EVs) and plasma membrane-derived exosome-mimetic
nanovesicles demonstrate significant potential for drug delivery. Latter
synthetic provides higher throughput over physiological EVs. However they face
size-stability and self-agglomeration challenges in physiological solutions to
be properly characterized and addressed. Here we demonstrate a fast and
high-throughput nanovesicle screening methodology relying on dynamic light
scattering (DLS) complemented by atomic force microscopy (AFM) measurements,
suitable for the evaluation of hydrodynamic size instabilities and aggregation
effects in nanovesicle solutions under varying experimental conditions and
apply it to the analysis of bio-engineered nanovesicles derived from
erythrocytes as well as physiological extracellular vesicles isolated from
animal seminal plasma. The synthetic vesicles exhibit a significantly higher
degree of agglomeration, with only 8 % of them falling within the typical
extracellular vesicle size range (30-200 nm) in their original preparation
conditions. Concurrent zeta potential measurements performed on both
physiological and synthetic nanovesicles yielded values in the range of -17 to
-22 mV, with no apparent correlation to their agglomeration tendencies.
However, mild sonication and dilution were found to be effective means to
restore the portion of EVs-like nanovesicles in synthetic preparations to
values of 54% and 63%, respectively, The results illustrate the capability of
this DLS-AFM-based analytical method for real-time, high-throughput and
quantitative assessments of agglomeration effects and size instabilities in
bioengineered nanovesicle solutions, providing a powerful and easy-to-use tool
to gain insights to overcome such deleterious effects and leverage the full
potential of this promising biocompatible drug-delivery carriers for a broad
range of pharmaceutical applications.
